Immunofixation Electrophoresis

The Immunofixation Electrophoresis (IFE) Urine test is a specialized diagnostic test used to detect and classify abnormal proteins, particularly monoclonal immunoglobulins, in urine. It is commonly used to diagnose and monitor conditions like multiple myeloma and other plasma cell disorders.

This test is performed to identify and differentiate between different types of abnormal protein production. It is often used when a patient has symptoms of multiple myeloma, amyloidosis, or monoclonal gammopathies and to track disease progression or response to treatment.

A urine sample, typically a 24-hour collection, is required. The sample undergoes electrophoresis, a laboratory process that separates proteins based on their electrical charge. Immunofixation is then used to detect and classify specific abnormal proteins.

Abnormal results may indicate the presence of monoclonal proteins (M-proteins), suggesting conditions like multiple myeloma, Waldenström’s macroglobulinemia, or light-chain amyloidosis. Further testing may be needed to confirm a diagnosis and determine the severity of the condition.

If abnormal proteins are detected, additional tests like serum protein electrophoresis, bone marrow biopsy, or imaging may be required. Treatment options depend on the underlying condition and may include chemotherapy, immunotherapy, or close monitoring in some cases.